Thomas E. Wagner, Ph.D.
Orbis was founded by Dr. Thomas Wagner, an internationally-renowned, award-winning pioneer of biomedical research and molecular biology. Dr. Wagner’s personal and scientific journey led him to develop and patent transgenic technology which has revolutionized the way we research cancer today. He was also among the first to develop methods of cell-based therapies, and for the past two decades, Dr. Wagner’s research has focused exclusively on the application of modern molecular and cellular biology to the development of new therapies for the treatment of cancer.
Dr. Wagner has served as a scientific advisor to the World Health Organization, to the U.S. Congress, and to the White House under former President Ronald Reagan.
Dr. Wagner has held prestigious faculty and research positions at Cornell University College of Medicine, The Sloan Kettering Institute for Cancer Research, Ohio University, Cambridge University, Ohio Edison Biotechnology Institute, Clemson University and the Greenville Hospital System University Medical Center. He has published more than 250 books and scientific papers in highly respected peer-reviewed biomedical journals and holds more than 50 patents.
Since 1998, Dr. Wagner’s research has focused exclusively on the application of modern molecular and cellular biology to the development of new therapies for the treatment of cancer.
He served as Director for the Oncology Research Institute of Greenville Hospital System, which is a national, award-winning leader in effectively applying advanced medical technology in the fight against cancer.
Dr. Wagner has served as a scientific advisor to the World Health Organization, to the US Congress, and to the White House of President Ronald Reagan. He has continued to lecture and keynote at major scientific conferences and congresses on innovations on biotechnology, gene transfer and cancer therapy.
Dr. Wagner is an experienced and successful entrepreneur. In addition to his contributions to Orbis and our affiliates he is also a cofounder of Diagnostic Hybrids, founded in 1983, which develops, manufactures and markets cellular and molecular diagnostic kits used to detect respiratory diseases, herpes infections, thyroid function, and other high value markers of disease. He a founder of the Ohio Edison Biotechnology Institute, and the GHS Oncology Research Institute.
Based on over 50 years of Dr. Wagner’s breakthrough scientific research and discovery, Orbis’ cutting-edge technology can deliver therapeutic opportunities for currently intractable diseases.